SE0002045D0 - New use - Google Patents

New use

Info

Publication number
SE0002045D0
SE0002045D0 SE0002045A SE0002045A SE0002045D0 SE 0002045 D0 SE0002045 D0 SE 0002045D0 SE 0002045 A SE0002045 A SE 0002045A SE 0002045 A SE0002045 A SE 0002045A SE 0002045 D0 SE0002045 D0 SE 0002045D0
Authority
SE
Sweden
Prior art keywords
new use
inflammations
etoposide
arthritis
mammals
Prior art date
Application number
SE0002045A
Other languages
English (en)
Swedish (sv)
Inventor
Andrej Tarkowski
Margareta Verdrengh
Original Assignee
Sahltech Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sahltech Ab filed Critical Sahltech Ab
Priority to SE0002045A priority Critical patent/SE0002045D0/xx
Publication of SE0002045D0 publication Critical patent/SE0002045D0/xx
Priority to EP01937095A priority patent/EP1311274A1/en
Priority to AU62861/01A priority patent/AU6286101A/en
Priority to PCT/SE2001/001217 priority patent/WO2001091760A1/en
Priority to US10/303,371 priority patent/US20030148963A1/en
Priority to HK03105343.0A priority patent/HK1053059A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE0002045A 2000-05-31 2000-05-31 New use SE0002045D0 (sv)

Priority Applications (6)

Application Number Priority Date Filing Date Title
SE0002045A SE0002045D0 (sv) 2000-05-31 2000-05-31 New use
EP01937095A EP1311274A1 (en) 2000-05-31 2001-05-31 New use
AU62861/01A AU6286101A (en) 2000-05-31 2001-05-31 New use
PCT/SE2001/001217 WO2001091760A1 (en) 2000-05-31 2001-05-31 New use
US10/303,371 US20030148963A1 (en) 2000-05-31 2002-11-25 Use of etoposide
HK03105343.0A HK1053059A1 (zh) 2000-05-31 2003-07-24 新用途

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0002045A SE0002045D0 (sv) 2000-05-31 2000-05-31 New use

Publications (1)

Publication Number Publication Date
SE0002045D0 true SE0002045D0 (sv) 2000-05-31

Family

ID=20279922

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0002045A SE0002045D0 (sv) 2000-05-31 2000-05-31 New use

Country Status (6)

Country Link
US (1) US20030148963A1 (zh)
EP (1) EP1311274A1 (zh)
AU (1) AU6286101A (zh)
HK (1) HK1053059A1 (zh)
SE (1) SE0002045D0 (zh)
WO (1) WO2001091760A1 (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006015341A1 (de) * 2006-04-03 2007-10-04 Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts Behandlung von multipler Sklerose und/oder rheumatoider Arthritis
GB0707208D0 (en) * 2007-04-13 2007-05-23 Istituto Superiore Di Sanito Novel disease treatments
EP2817007A1 (en) * 2012-02-24 2014-12-31 Nestec S.A. Peltatin for the treatment of chronic inflammatory disorders

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6613143A (zh) * 1965-09-21 1967-03-22
FR2725990B1 (fr) * 1994-10-21 1997-01-10 Pf Medicament Derives hydrosolubles d'epipodophyllotoxine, leur procede de preparation, leur utilisation a titre de medicament, et leur utilisation destinee aux traitements anticancereux
US6040306A (en) * 1997-11-18 2000-03-21 Pharmacia & Upjohn Company Method of treating psoriasis, arthritis and reducing the toxicity of cancer chemotherapy
GB9814036D0 (en) * 1998-06-29 1998-08-26 Univ Dundee Materials and methods relating to the induction of apoptosis in target cells
US6395718B1 (en) * 1998-07-06 2002-05-28 Guilford Pharmaceuticals Inc. Pharmaceutical compositions and methods of inhibiting angiogenesis using naaladase inhibitors
EP2000136A3 (en) * 2000-02-28 2008-12-31 The University of British Columbia Compositions and methods for the treatment of inflammatory diseases using topoisomerase inhibitors

Also Published As

Publication number Publication date
EP1311274A1 (en) 2003-05-21
AU6286101A (en) 2001-12-11
US20030148963A1 (en) 2003-08-07
HK1053059A1 (zh) 2003-10-10
WO2001091760A1 (en) 2001-12-06

Similar Documents

Publication Publication Date Title
MXPA03011546A (es) Formulacion farmaceutica.
BG66084B1 (bg) Циклопентаноиндоли, състави,съдържащи такива съединения и използването им
SE0101675D0 (sv) Novel composition
PT1309589E (pt) Compostos de ureia e metodos de utilizacao
ATE263157T1 (de) Nematizide trifluorbutene
DE60225040D1 (de) Montelukast-granulatformulierung
DE60230890D1 (de) Indolizine als kinaseproteinhemmer
SE0102315D0 (sv) Compounds
PT1411908E (pt) Tratamento de infeccoes da unha com no
ATE417051T1 (de) Polymorphe von clopidogrel-hydrogensulfat
ECSP055584A (es) Proceso para la preparación de fibrinógeno
MXPA02010627A (es) Derivados de 2-acil-indol y su uso como farmaco antitumoral.
BR0306922A (pt) N-pirazinil-fenilsulfonamidas e seu uso no tratamento de doenças mediadas por quimocina
DE60207890D1 (de) Neue verbindungen
ATE330017T1 (de) Kallikrein gen
DK1315506T3 (da) Phospholipidderivater af valproinsyre og blandinger deraf
DE60207759D1 (de) Pyrimidotriazine als phosphataseinhibitoren
SE9901077D0 (sv) Novel use
SE9801494D0 (sv) Novel use
ATE335739T1 (de) Cak inhibitoren und deren verwendungen
EA200500326A1 (ru) Применение ферментированного экстракта проростков пшеницы в качестве противовоспалительного агента
SE0002045D0 (sv) New use
SE0001631D0 (sv) New use
BRPI0417205A (pt) composições farmacêuticas
ES2192034T3 (es) Feniluracilos substituidos con efecto herbicida.